Details for Patent: 5,529,791
✉ Email this page to a colleague
Summary for Patent: 5,529,791
| Title: | Extended release form of diltiazem |
| Abstract: | An extended-release galenical form of Diltiazem or a pharmaceutically acceptable salt thereof, which comprises beads containing said Diltiazem or a pharmaceutically acceptable salt thereof as an active ingredient and a wetting agent, said beads being coated with a microporous membrane comprising at least a water-soluble or water-dispersible polymer or copolymer and a pharmaceutically acceptable adjuvant. |
| Inventor(s): | Deboeck; Arthur M. (Gurabo, PR), Baudier; Philippe R. (Waterloo, BE) |
| Assignee: | Galephar P.R., Inc., Ltd. (Carolina, PR) |
| Application Number: | 08/311,722 |
|
Patent Claim Types: see list of patent claims | Composition; |
Drugs Protected by US Patent 5,529,791
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,529,791
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 184196 | ⤷ Sign Up | |||
| Australia | 2243092 | ⤷ Sign Up | |||
| Canada | 2111085 | ⤷ Sign Up | |||
| Germany | 69229949 | ⤷ Sign Up | |||
| Denmark | 0591424 | ⤷ Sign Up | |||
| European Patent Office | 0591424 | ⤷ Sign Up | |||
| World Intellectual Property Organization (WIPO) | 9300093 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
